Abstract: Packaging multiple small interfering RNA (siRNA) molecules into nanostructures at precisely defined ratios is ap owerful delivery strategy for effective RNAi nterference (RNAi)t herapy. We present an ovel RNAn anotechnology based approach to produce multiple components of polymerized siRNAm olecules that are simultaneously self-assembled and densely packaged into composite sponge-like porous microstructures (Multi-RNAi-MSs) by rolling circle transcription. The Multi-RNAi-MSs were designed to contain acombination of multiple polymeric siRNAm olecules with precisely controlled stoichiometry within as ingular microstructure by manipulating the types and ratios of the circular DNA templates.T he Multi-RNAi-MSs were converted into nanosized complexes by polyelectrolyte condensation to manipulate their physicochemical properties (size, shape,a nd surface charge) for favorable delivery,w hile maintaining the multifunctional properties of the siRNAs for combined therapeutic effects.T hese Multi-RNAi-MS systems have great potential in RNAi-mediated biomedical applications,f or example,f or the treatment of cancer,g enetic disorders,a nd viral infections.
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KeyaspectsofRNAnanotechnology [1] rely on the functional diversities of RNAm olecules (e.g., gene silencing,c atalytic activity,a nd regulatory roles) and their structural complexities (e.g., secondary structure motifs and loops).
[2] These properties of RNAs as biologically functional nanomaterials enable the construction of RNA-based nanostructures for numerous biological and therapeutic applications. [3] Furthermore,R NA interference (RNAi)b ased therapy using small interfering RNA( siRNA) has been intensely investigated as ap owerful approach for therapeutic applications,i ncluding cancer treatment, because of its unique capacity for achieving sequence-specific gene silencing. [4] By combining structural RNAn anotechnology and RNAi, we recently developed as elf-organized RNAi delivery approach based on the selfassembly of highly concentrated and polymerized siRNAinto sponge-like porous magnesium pyrophosphate microstructures (RNAi-MSs). [5, 6] To enhance both intracellular and systemic delivery of polymeric nucleic acids,m odification of the microsponge structure can be achieved in two steps: 1) condensation of the microsponge structures into nanostructure complexes,and 2) progressive electrostatic layer-bylayer (LbL) adsorption of various biomaterials onto the condensed nanoparticles. [7] Building on these previous findings,t he next critical challenge with this delivery system was to expand the versatility and practicality of delivering RNAi molecules for potent therapeutic efficacy. Several disorders and clinical conditions are the result of genetic dysregulation, often impacted by multiple gene pathways that can be highly interdependent. To achieve synergistic and effective therapies based on RNAi, the simultaneous controlled release of multiple siRNAs may be required, and in many cases,t he relative amounts and/or timeframes of suppression can require precision approaches towards delivery. [4, 8] Ap romising approach would be to stably,safely,and effectively deliver large quantities of multiple RNAi molecules into targeted tumors in ac ontrolled manner. [9] To address these critical issues,w eh erein report am odular platform for synthesizing multiple components of polymeric RNAi molecules that selfassemble into microsponge structures (Multi-RNAi-MSs) by rolling circle transcription (RCT). Thet ypes and ratios of multiple polymeric RNAi molecules within individual RNAi microsponge structures are easily manipulated depending on the circular DNAt emplate design and fine-tuning of the reaction conditions at the RCT stage.T hese packaged multiple polymeric RNAi molecules can be further assembled into nanoparticles by ac ondensation step,l eading to favorable physicochemical properties for efficient cellular uptake. As ar esult, the Multi-RNAi-MS method represents am eans of producing well-controlled, multifunctional, biocompatible, polymeric RNAi molecules designed for the simultaneous silencing of genes,b oth in terms of packaging and delivery efficacy.
To generate microsponges containing multiple types of polymeric RNAi molecules,w ef irst designed linear DNA template sequences (Table S1 ) and then constructed acircular DNAl ibrary.E ach linear single-stranded DNA( ssDNA) template was comprised of complementary sense and anti-sense siRNAs equences,s pacer regions,m olecular-probe recognition sites,a nd primer-binding sites ( Figure 1A ). As ap roof of concept to test the different siRNAf unctions of multiple polymeric RNAi molecules,t he siRNAs were designed with complementary sense and antisense sequences corresponding to two different reporter genes [i.e., green fluorescent protein (GFP) and red fluorescent protein (RFP)].T he various circular DNAs used to construct the modular library of polymeric RNAi molecules were synthesized by hybridizing linear DNAs to complementary primers and performing enzymatic ligations.G el electrophoresis was conducted to confirm the generation of circular DNA structures from these hybridized and ligated linear strands. Band shifts reflecting the conversion of linear DNAs into circular DNAs were observed, demonstrating the successful generation of ac ircular DNAl ibrary (Supporting Information, Figure S1 ). By using predefined sets of circular DNAs during RCT,m ultiple functional types of polymeric RNAi molecules were simultaneously generated, which could then self-assemble to form Multi-RNAi-MSs ( Figure 1B) .
After purification to obtain well-dispersed Multi-RNAiMSs,t he morphologies and structures of the Multi-RNAiMSs (with the GFP and RFP polymeric RNAi molecules in ar atio of 1:1) were investigated by scanning electron microscopy (SEM), confocal microscopy,a nd transmission electron microscopy (TEM). TheS EM image shows that the Multi-RNAi-MSs were spherical in shape and uniformly micrometer-sized composite particles (ca. 1 mmd iameter) with as ponge-like surface porosity (Figure 2A ). Them orphological characteristics of the Multi-RNAi-MSs were further studied by confocal microscopy to observe the presence and distribution of the multiple polymeric RNAi molecules in the microsponges.F or this approach, we used Cy5-UTP labeling during the RCT process,yielding polymeric RNAi molecules with red fluorescence (Figure 2B ). Ther ed fluorescence in the confocal microscopy image indicated that the polymeric RNAt ranscripts were distributed fairly evenly throughout the particles,w hich consist of the polymeric transcripts bound to crystalline magnesium pyrophosphate scaffolds.F urthermore,t he TEM image showed that the structures of the Multi-RNAi-MSs comprise highly compact, multilayered thin sheets that branch hierarchically outwards from ad ense inner core ( Figure 2C and Figure S2 ). TheM ulti-RNAi-MSs were further analyzed by cryo-TEM to determine their complex structures in anative environment without dehydration ( Figure 2D ). Thecryo-TEM image more clearly shows the extensive nanocrystalline structure of the particles, and suggests al arge internal surface area within the sheet-like crystals.
It is important to note that this facile engineering approach for synthesizing Multi-RNAi-MSs can incorporate different ratios/combinations of multiple polymeric RNAi molecules to elicit various biological responses.T he relative amounts of the different polymeric RNAi molecules that were incorporated into the microsponges were easily manipulated by controlling the ratios of circular DNAs combined in the RCT reactions.F ive types of Multi-RNAi-MSs were constructed by controlling the ratios of the RNAcomponents. Their construction was based on varying the molar ratio of the two different circular DNAt emplates (4:1, 2:1, 1:1, 1:2, and 1:4) that were used for the RCT reactions.A fter the RCT process,t wo molecular probes [fluorescently tagged short oligonucleotides (ca. 20 bases) with green or red fluorescence] were hybridized to the pre-designed recognition sites encoded into each of the two polymeric RNAi molecules of the microsponges.T his hybridization resulted in merged fluorescence signals whose relative component intensities depended on the molar ratio of the polymeric RNAi molecules generated within each Multi-RNAi-MS type. Therefore,d ifferent Multi-RNAi-MSs (4G1R, 2G1R, 1G1R, 1G2R, and 1G4R) could be decoded by determining the fluorescence intensity ratios between the sequence-specific probes.C onfocal microscopy was utilized to confirm the presence of the two polymeric RNAi molecule components within individual microsponge structures by observing the merged fluorescence intensities.T he fluorescence intensity ratio varied as afunction of the ratio of the polymeric RNAi molecules incorporated into the Multi-RNAi-MSs (Figure 3A) . In this manner,w ec onfirmed that the expected and observed fluorescent intensity ratios of the Multi-RNAiMSs were highly correlated, indicating the successful incorporation of polymeric RNAi molecules at the intended ratios during the synthesis of the microsponge structures.T he presence of multiple components within each singular RNAi microsponge structure was further confirmed by flow cytometry analysis.The ratio of the normalized intensities was calculated as I R /I G ,w here I R and I G are the red and green fluorescence intensities from both nucleic acid tags in the Multi-RNAi-MSs,r espectively.T hese results also demonstrated the feasibility of precisely controlling the relative amounts of multiple components of polymeric RNAi molecules within Multi-RNAi-MSs by varying the ratio of the hybridized DNAt emplates ( Figure 3B) .
It is necessary to obtain RNAi particles with appropriate physicochemical properties,w ith respect to size,s hape,a nd surface charge,especially for practical biological applications such as systemic drug delivery. [10] Our strategy for developing Multi-RNAi-MSs as ad rug-delivery platform involved an additional condensation step by electrostatic interactions and physical agitation. [5] [6] [7] In this study,p ositively charged linear polyethylenimine (PEI) was chosen to achieve effective intracellular uptake and endosomal escape.W eo bserved the additional packaging of polymeric RNAi molecules by PEI-induced condensation. Confocal microscopy images revealed that the size of the Multi-RNAi-MSs was reduced in the presence of PEI (1 mg mL À1 )a fter the condensation process ( Figure 4A,B) . We further examined the presence of multiple polymeric RNAi molecules in the condensed particles ( Figure S3 ). Them orphology and physical size of the condensed structures were further analyzed by TEM and compared with the structures of the original Multi-RNAiMSs.W eobserved the formation of uniform polyplex structures,a nd the average particle size of the condensed particles was approximately 102 nm ( Figure 4C and Figure S4) . Furthermore,t he size and surface charge of the Multi-RNAi-MSs before and after the condensation step were determined by dynamic light scattering (DLS) and zeta potential measurements,c onfirming the ability to reverse particle surface charge and the successful condensation of the Multi-RNAi-MSs with PEI ( Figure S5 ). These results suggest that the Multi-RNAi-MSs were transformed in terms of their structural morphology,p article size,a nd surface charge by disruption of the negatively charged Multi-RNAi-MSs and subsequent complexation with ap ositively charged polymer. We refer to these highly compact, nanosized complex particle structures consisting of multiple polymeric RNAi molecules as Multi-RNAi-NPs.
To address potential biomedical applications of our engineered platform, we further investigated the efficacyo f the Multi-RNAi-NPs with respect to enzyme (Dicer) processing,c ellular delivery,g ene silencing,a nd cellular cytotoxicity ( Figure S6 ). Dicer processing showed that the MultiRNAi-MSs contained multiple polymeric RNAi molecules while retaining their biological capacity.M ulti-RNAi-NPs (GFP-RFP-RNAi-MS/PEI) were transfected into cancer cells (HeLa cells), and the cellular uptake was analyzed. The Multi-RNAi-NPs were labeled with fluorescent Cy5-UTP (red) during the RCT process.C onfocal microscopy images show that the Multi-RNAi-NPs were successfully delivered to cells ( Figure 4D ). This cellular uptake was attributed to endocytosis because no fluorescence was observed inside the Figure 3 . Characterization of Multi-RNAi-MSs obtained with the ratio control system.A )Confocal microscopyimages of Multi-RNAi-MSs prepared according to the ratio control system.F ive types of MultiRNAi-MSs containing various amounts of polymericR NAi molecules were synthesized by subjectingv arious combinationso fcircular DNA templates to RCT.The Multi-RNAi-MSs were hybridized with two fluorescent-dye-conjugated nucleic acid probes after the RCT process (yielding green or red fluorescence). Scale bars:5mmand 500 nm (inset). B) Flow cytometry analysis of the Multi-RNAi-MSs. The green channel indicates FITC and the red channel indicates APC. The R 2 value refers to the correlationb etween the observed green/red fluorescence intensity ratio and the pre-determined green/red polymeric RNAi molar ratio.
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Communications cells when endocytosis was inhibited by incubation at 4 8 8C ( Figure S7 ). TheM ulti-RNAi-NP platform can be used to incorporate siRNAs targeting several mRNAs on the cellular level. As aproof of concept for the hypothesis that more than one gene can be silenced with Multi-RNAi-NPs,itwas shown that HeLa cells that were engineered to stably overexpress GFP and RFP exhibited substantial target gene knockdown in ad ose-dependent manner after the cellular uptake of MultiRNAi-NPs.W ith ap redefined combination ratio of 1:1( the molar ratio between the two polymeric RNAi molecules in GFP-RFP-RNAi-MS/PEI), the GFP and RFP expression levels were silenced by (52 AE 5) %a nd (25 AE 4) %, respectively,ataconcentration of 8nm ( Figure 4E ). Theviability of cancer cells at 48 hp ost-transfection with Multi-RNAi-NPs was subsequently measured by an MTT assay.T ransfection with PEI-condensed Multi-RNAi-NPs was associated with much higher cell viabilities after removing the excess unincorporated PEI in ap urification process following the condensation step ( Figure 4F ). It is notable that the knockdown increases with increasing concentrations for both the GFP and RFP RNAi sequences,i ndicating that the knockdown scales equally for both systems in these multi-RNAi sequences.F urthermore,a ll Multi-RNAi-MSs (i.e., 4G1R, 2G1R, 1G1R, 1G2R, and 1G4R) were evaluated for knockdown of the target mRNAs,indicating the ratio controllability of the in vitro knockdown with the Multi-RNAi-MSs system ( Figure S8) . Overall, the engineered Multi-RNAi-NPs were efficiently taken up by cells and facilitated efficient targeting of multiple genes,achieving silencing with negligible cytotoxicity.
In summary,t he RCT generation of polymeric RNAi systems is versatile,and enables the production of polymeric RNAi for the silencing of multiple genes within the same RNAi-MS.W eh ave developed an ovel platform for efficiently packaging and delivering multiple RNAi molecules, which is thus capable of simultaneously regulating multiple biological functions.Asthe encoded RNAstrands were easily modified by circular DNAt emplate design, we could incorporate numerous polymeric RNAi molecules into as ingle Multi-RNAi-MS,e xpanding both their versatility and applicability.U sing ac ombination of hybrid DNA templates,r atiometric composites of polymeric RNAi could be rationally engineered, allowing for precise control over the stoichiometry of the RNAi repeats.W ith an appropriate condensation method, the resulting nanosized delivery platform facilitated efficient RNAi in cancer cells.Our approach to efficiently package and simultaneously deliver multiple polymeric RNAi molecules could provide additive and synergistic effects for RNAi-based cancer therapy. 
